Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Insiders Buying Edgewise Therapeutics And 2 Other Stocks

Author: Avi Kapoor | January 26, 2024 07:34am

Although U.S. stocks closed higher on Thursday, there were a few notable insider trades.

When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go long on the stock. Insider purchases should not be taken as the only indicator for making an investment or trading decision. At best, it can lend conviction to a buying decision.

Below is a look at a few recent notable insider purchases. For more, check out Benzinga's insider transactions platform.

Tile Shop

  • The Trade: Tile Shop Holdings, Inc. (NASDAQ:TTSH) 10% owner Pleasant Lake Partners LLC acquired a total of 14,600 shares an average price of $6.73. To acquire these shares, it cost around $98,288.
  • What’s Happening: Tile Shop Holdings, during November, posted downbeat quarterly sales.
  • What Tile Shop Does: Tile Shop Holdings Inc is a specialty retailer of natural stone and man-made tiles, setting and maintenance materials, and related accessories in the United States.

Edgewise Therapeutics

  • The Trade: Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Director Peter A Thompson acquired a total of 454,545 shares at an average price of $11.00. To acquire these shares, it cost around $5 million.
  • What’s Happening: Edgewise Therapeutics announced pricing of its $240 million underwritten offering of 21,818,182 shares at $11 per share.
  • What Edgewise Therapeutics Does: Edgewise Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of innovative treatments for severe, rare muscle disorders.

Don’t forget to check out our premarket coverage here

Wolfspeed

  • The Trade: Wolfspeed, Inc. (NYSE:WOLF) Director Thomas H Werner bought a total of 683 shares at an average price of $32.05. To acquire these shares, it cost around $21,889.
  • What’s Happening: Wolfspeed and Infineon announced the expansion and extension of their existing long-term 150mm silicon carbide wafer supply agreement.
  • What Wolfspeed Does: Wolfspeed Inc is involved in the manufacturing of wide bandgap semiconductors. It is focused on silicon carbide and gallium nitride materials and devices for power and radio-frequency (RF) applications.

 

Check This Out: Intel, American Express And 3 Stocks To Watch Heading Into Friday

Posted In: EWTX TTSH WOLF

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist